Faculty profile

Jean-Francois Yale

Back to faculty

ProfessorDepartment of MedicineMcGill University

Jean-Francois Yale

Professor

Department of Medicine

Faculty of Medicine and Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
2 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

289

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Other departments

Division of Endocrinology and Metabolism Research Institute - McGill University Health Centre (RI MUHC)

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their McGill University profile.

Complications diabetes hypoglycemia intensive therapy prevention

Latest papers

A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies.
Diabetes, obesity & metabolism · 2026
Can continuous glucose monitoring technology reduce fear of hypoglycemia in people with type 1 diabetes?
Polish archives of internal medicine · 2022 · senior author
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.
Diabetes, obesity & metabolism · 2021

All 12 publications

Latest funding

Quebec Integrated Health Research Network (IHRN).
CFI · 2000 · Co-investigator
$11,302,048

All 1 grants and awards

12 publications.

A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies.

Katz A, Shulkin A, Housni A, Roy-Fleming A, Rabasa-Lhoret R, Yale JF, Tsoukas MA, Peters TM, Brazeau AS

Diabetes, obesity & metabolism20263 citationsOpen Access

DOI: 10.1111/dom.70465 PMID: 41521936

Can continuous glucose monitoring technology reduce fear of hypoglycemia in people with type 1 diabetes?

Talbo MK, Peters T, Brazeau AS, Rabasa-Lhoret R, Yale JF

Polish archives of internal medicine20221 citationsSenior authorOpen Access

DOI: 10.20452/pamw.16209 PMID: 35226443

Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.

Haidar A, Yale JF, Lovblom LE, Cardinez N, Orszag A, Falappa CM, Gouchie-Provencher N, Tsoukas MA, El Fathi A, Rene J, Eldelekli D, Lanctôt SO, Scarr D, Perkins BA

Diabetes, obesity & metabolism202143 citations

DOI: 10.1111/dom.14335 PMID: 33528904

Cardiovascular risk factor management in patients with diabetes: Does management differ with disease duration?

Lo S, Leiter LA, Langer A, Tan M, Goldin L, Harris S, Yale JF, Ekoe JM, Lin PJ, Goodman SG, Yan AT

Journal of diabetes and its complications20213 citations

DOI: 10.1016/j.jdiacomp.2021.107997 PMID: 34332851

A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.

Haidar A, Tsoukas MA, Bernier-Twardy S, Yale JF, Rutkowski J, Bossy A, Pytka E, El Fathi A, Strauss N, Legault L

Diabetes care2020137 citations

DOI: 10.2337/dc19-1922 PMID: 31974099

CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes Management

Mancini GBJ, Cheng AY, Connelly K, Fitchett D, Goldenberg R, Goodman S, Leiter LA, Lonn E, Paty B, Poirier P

Canadian Journal of Cardiology20184 citationsSenior authorOpen Access

DOI: 10.1016/j.cjca.2018.07.010

A Practical Guide to the Use of Glucose-Lowering Agents With Cardiovascular Benefit or Proven Safety

Fitchett D, Cheng A, Connelly K, Goldenberg R, Goodman SG, Leiter LA, Lonn E, Paty B, Poirier P, Stone J

Canadian Journal of Cardiology20176 citations

DOI: 10.1016/j.cjca.2017.04.012

Acute Management and Outcomes of Patients with Diabetes Mellitus Presenting to Canadian Emergency Departments with Hypoglycemia

Rowe BH, Singh M, Villa-Roel C, Leiter LA, Hramiak I, Edmonds ML, Lang E, Sivilotti M, Scheuermeyer F, Worster A

Canadian Journal of Diabetes201523 citationsOpen Access

DOI: 10.1016/j.jcjd.2014.04.001

Acute Management and Outcomes of Patients with Diabetes Mellitus Presenting to Canadian Emergency Departments with Hypoglycemia

Rowe BH, Singh M, Villa-Roel C, Leiter LA, Hramiak I, Edmonds ML, Lang E, Sivilotti M, Scheuermeyer F, Worster A

Canadian Journal of Diabetes20156 citations

DOI: 10.1016/j.jcjd.2015.09.084

Health economic evaluation of type 2 diabetes mellitus: a clinical practice focused review.

Liebl A, Khunti K, Orozco-Beltran D, Yale JF

Clinical medicine insights. Endocrinology and diabetes2015Senior author

DOI: 10.4137/cmed.s20906 PMID: 25861233

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Jean-Francois Yale

Research

Latest papers

Latest funding

A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies.

Can continuous glucose monitoring technology reduce fear of hypoglycemia in people with type 1 diabetes?

Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.

Cardiovascular risk factor management in patients with diabetes: Does management differ with disease duration?

A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.

CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes Management

A Practical Guide to the Use of Glucose-Lowering Agents With Cardiovascular Benefit or Proven Safety

Acute Management and Outcomes of Patients with Diabetes Mellitus Presenting to Canadian Emergency Departments with Hypoglycemia

Acute Management and Outcomes of Patients with Diabetes Mellitus Presenting to Canadian Emergency Departments with Hypoglycemia

Health economic evaluation of type 2 diabetes mellitus: a clinical practice focused review.

Quebec Integrated Health Research Network (IHRN).

Frequent collaborators

Lawrence Leiter

Marco Sivilotti

Shaun Goodman

Jennifer Riley

Paul Poirier

Eva Lonn

Eddy Lang

Brian Rowe

Anne-Sophie Brazeau

Ahmad Haidar

Kim Connelly

Marc Afilalo

Ian Stiell

Samuel Campbell

Frank Scheuermeyer

Michael Tsoukas

Andrew Worster

David Thompson

Alice Cheng

Anatoly Langer

Subodh Verma

Hertzel Chaim Gerstein

Jackie Bosch

Hertzel Gerstein

Stewart Harris